Addex Therapeutics Ltd (ADXN)
8.79
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
8.78
-0.01
(-0.11%)
After-Hours: 20:00
Addex Therapeutics Accounts Payable (Quarterly): 1.172M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.172M |
| September 30, 2023 | 0.426M |
| June 30, 2023 | 1.239M |
| March 31, 2023 | 1.178M |
| December 31, 2022 | 1.377M |
| September 30, 2022 | 3.071M |
| June 30, 2022 | 1.906M |
| March 31, 2022 | 1.540M |
| December 31, 2021 | 1.955M |
| September 30, 2021 | 1.238M |
| June 30, 2021 | 1.313M |
| March 31, 2021 | 2.367M |
| December 31, 2020 | 1.126M |
| September 30, 2020 | 0.4711M |
| June 30, 2020 | 1.008M |
| March 31, 2020 | 2.336M |
| December 31, 2019 | 2.287M |
| June 30, 2019 | 1.939M |
| December 31, 2018 | 1.167M |
| June 30, 2018 | 1.006M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.006M |
| December 31, 2017 | 0.3934M |
| June 30, 2017 | 0.2744M |
| June 30, 2017 | 0.2744M |
| December 31, 2016 | 0.6581M |
| June 30, 2016 | 0.353M |
| June 30, 2016 | 0.353M |
| December 31, 2015 | 0.1729M |
| June 30, 2015 | 0.1641M |
| June 30, 2015 | 0.1641M |
| December 31, 2014 | 0.6546M |
| June 30, 2014 | 0.9375M |
| June 30, 2014 | 0.9375M |
| December 31, 2013 | 0.6826M |
| June 30, 2013 | 1.729M |
| June 30, 2013 | 1.729M |
| December 31, 2012 | 0.7773M |
| June 30, 2012 | |
| June 30, 2012 | |
| December 31, 2011 | 9.052M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.426M
Minimum
Sep 2023
3.071M
Maximum
Sep 2022
1.553M
Average
1.345M
Median
Accounts Payable (Quarterly) Benchmarks
| AC Immune SA | 3.144M |
| CRISPR Therapeutics AG | 16.46M |
| NLS Pharmaceutics Ltd | 3.113M |
| Molecular Partners AG | 0.4881M |
| MoonLake Immunotherapeutics | 1.630M |